By Mark DaCosta- As our nation grapples with the ongoing challenges of public health, the recent epidemiological update from the Pan American Health Organization (PAHO) serves as a stark reminder of the persistent threat posed by dengue fever. This mosquito-borne disease has reached alarming levels across the Americas, underscoring the urgent need for robust preventive measures and vigilant health systems in Guyana.
In 2025, the region was beset by a staggering 4,459,521 suspected cases of dengue, with 1,682,588 confirmed diagnoses. The severity of this outbreak cannot be overstated, as it resulted in 8,966 instances of severe dengue and a tragic 2,207 deaths, reflecting a case fatality rate of 0.05 percent. However, in a somewhat hopeful turn, these figures represent a significant reduction of 66 percent in cases and 74 percent in fatalities compared to the previous year, which was marked by the highest recorded numbers in recent history.
Nevertheless, the distribution of cases across various subregions has yielded concerning trends. While the Southern Cone reported the highest number of dengue cases in 2025, it also experienced a commendable 65 percent decrease from the previous year. Conversely, the Caribbean region witnessed a disturbing 7 percent increase in cases, more than doubling the average seen between 2019 and 2023. Such trends highlight the critical need for our nation to remain on high alert and to bolster its health systems against potential outbreaks.
As we stepped into 2026, the situation appeared even more pressing. By the end of January, 122,090 cases had already been reported, with 22,409 confirmed cases, 242 suffering from severe dengue, and six fatalities. This marks a stark 83 percent decrease in cases and a remarkable 98 percent reduction in deaths compared to the same period in 2025, but it is essential to approach this data with caution and not let complacency set in.
In its recent communication, PAHO strongly emphasises the importance of “strengthening integrated surveillance — epidemiological, clinical, laboratory, and entomological” as a key strategy to combat dengue. Furthermore, the organisation calls for enhanced vector control in high-risk areas, including health facilities, which underscores the vulnerability of our health systems in effectively tackling this ever-present threat. Early clinical diagnosis, monitoring warning signs such as severe abdominal pain and persistent vomiting, and adapting health services for timely care are paramount to ensure we avoid succumbing to a dengue crisis.
To understand the backdrop against which these alarming statistics unfold, it is crucial to comprehend the nature of dengue itself. The disease, caused by four distinct serotypes of the dengue virus, is primarily transmitted by the Aedes aegypti mosquito. Transmission occurs when a mosquito bites an infected person, subsequently passing the virus to a healthy individual. It is notable that while recovery from one dengue serotype grants lifelong immunity to that strain, infection by subsequent serotypes significantly raises the risk of developing severe dengue, complicating the challenges presented in controlling outbreaks.
Symptoms of dengue typically emerge four to ten days post-infection and can range from mild feverish reactions to debilitating conditions. High fever, sharp headaches, muscle and joint pain and swelling, nausea, and a distinctive skin rash are common indicators of the illness. The disease progresses through three phases: Febrile (fever), Critical, and Recovery. Unfortunately, some patients experience a transition into the critical phase when fever subsides, which can lead to severe complications such as fluid accumulation and bleeding — resulting in what is known as Dengue Hemorrhagic Fever (DHF).
As a nation, we must remain cognisant of the vulnerabilities faced by our communities, especially in urban areas with poor sanitation and stagnant water — breeding grounds for mosquitoes. Children and the elderly are particularly susceptible, and this becomes an even greater concern for those with underlying health conditions, such as chronic obstructive pulmonary disease (COPD), which can exacerbate respiratory complications arising from severe dengue.
Currently, there is no specific antiviral treatment for dengue, and management remains focused on supportive care. Hydration is crucial, as is pain management, wherein acetaminophen is preferred over NSAIDs like ibuprofen or aspirin due to their potential to increase bleeding risks. Severe cases may require hospitalisation, intravenous fluids, and blood transfusions, thus straining our healthcare facilities.
Given the absence of a widely available cure, prevention strategies focus on tackling the roots of dengue transmission. Environmental management — ensuring the elimination of standing water where mosquitoes breed — must be a priority for our communities. Furthermore, citizens are encouraged to adopt personal protective measures by using insect repellents containing DEET, wearing long-sleeved attire, and utilising mosquito nets.
As the PAHO emphasises, “Countries must remain attentive to potential changes in the epidemiological situation” and adapt their responses promptly. Our nation must prioritise these preventative measures and push for stronger government action in safeguarding public health. The statistics paint a sobering picture, and it is imperative that we do not let these realities slip into a false sense of security.
As we strive for a healthier future for our citizens, it is vital to engage in preventive action and demand accountability from our leaders. Our health is not just a personal responsibility but a collective obligation to ensure the well-being of our nation against the backdrop of dengue’s unpredictable and persistent threat.
